<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36320012</PMID><DateCompleted><Year>2022</Year><Month>11</Month><Day>03</Day></DateCompleted><DateRevised><Year>2022</Year><Month>11</Month><Day>05</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1741-7015</ISSN><JournalIssue CitedMedium="Internet"><Volume>20</Volume><Issue>1</Issue><PubDate><Year>2022</Year><Month>Nov</Month><Day>02</Day></PubDate></JournalIssue><Title>BMC medicine</Title><ISOAbbreviation>BMC Med</ISOAbbreviation></Journal><ArticleTitle>Investigation of the causal relationship between ALS and autoimmune disorders: a Mendelian randomization study.</ArticleTitle><Pagination><StartPage>382</StartPage><MedlinePgn>382</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">382</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s12916-022-02578-9</ELocationID><Abstract><AbstractText Label="BACKGROUND">Epidemiological studies have reported an association between amyotrophic lateral sclerosis (ALS) and different autoimmune disorders. This study aims to explore the causal relationship between autoimmune disorders and ALS using Mendelian randomization (MR).</AbstractText><AbstractText Label="METHODS">To test the genetically predicted effects of liability towards immune-related outcomes on ALS risk, we used summary statistics from the largest European genome-wide association studies (GWAS) for these disorders in a two-sample MR setting. To do this, we extracted single nucleotide polymorphisms (SNPs) from the GWAS, which strongly associated with the 12 traits, and queried their effects in a large European ALS GWAS (27,265 cases and 110,881 controls). To avoid bias in our MR instruments related to the complex linkage disequilibrium structure of the human leukocyte antigen (HLA) region, we excluded SNPs within this region from the analyses. We computed inverse-variance weighted (IVW) MR estimates and undertook sensitivity analyses using MR methods robust to horizontal pleiotropy. We also performed a reverse MR analysis testing the causal effects of ALS on the above autoimmune traits.</AbstractText><AbstractText Label="RESULTS">After applying Bonferroni correction for multiple testing, our MR analyses showed that the liability to autoimmune disorders does not affect ALS risk. Our reverse MR analysis also did not support the effects of liability to ALS on other autoimmune disorders. The results of the main IVW MR analyses were generally supported by our sensitivity MR analyses. The variance in the exposures explained by the sets of SNPs used as MR instruments ranged from 8.1 &#xd7; 10<sup>-4</sup> to 0.31. Our MR study was well-powered to detect effects as small as an odds ratio (OR) of 1.045 for ALS in the main MR and as small as an OR of 1.32 in the reverse MR.</AbstractText><AbstractText Label="CONCLUSION">Our MR study does not support a relationship between liability to autoimmune disorders and ALS risk in the European population. The associations observed in epidemiological studies could be partly attributed to shared biology or environmental confounders.</AbstractText><CopyrightInformation>&#xa9; 2022. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Alipour</LastName><ForeName>Paria</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Montreal Neurological Institute and Hospital, McGill University, Montr&#xe9;al, QC, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Human Genetics, McGill University, Montr&#xe9;al, QC, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Senkevich</LastName><ForeName>Konstantin</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Montreal Neurological Institute and Hospital, McGill University, Montr&#xe9;al, QC, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurology and Neurosurgery, McGill University, Montr&#xe9;al, QC, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ross</LastName><ForeName>Jay P</ForeName><Initials>JP</Initials><AffiliationInfo><Affiliation>Montreal Neurological Institute and Hospital, McGill University, Montr&#xe9;al, QC, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Human Genetics, McGill University, Montr&#xe9;al, QC, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Spiegelman</LastName><ForeName>Dan</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Montreal Neurological Institute and Hospital, McGill University, Montr&#xe9;al, QC, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurology and Neurosurgery, McGill University, Montr&#xe9;al, QC, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Manousaki</LastName><ForeName>Despoina</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Biochemistry and Molecular Medicine, University of Montreal, Montr&#xe9;al, QC, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pediatrics, University of Montreal, Montr&#xe9;al, QC, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Research Center of the Sainte-Justine University Hospital, Montr&#xe9;al, QC, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dion</LastName><ForeName>Patrick A</ForeName><Initials>PA</Initials><AffiliationInfo><Affiliation>Montreal Neurological Institute and Hospital, McGill University, Montr&#xe9;al, QC, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Human Genetics, McGill University, Montr&#xe9;al, QC, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rouleau</LastName><ForeName>Guy A</ForeName><Initials>GA</Initials><AffiliationInfo><Affiliation>Montreal Neurological Institute and Hospital, McGill University, Montr&#xe9;al, QC, Canada. guy.rouleau@mcgill.ca.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Human Genetics, McGill University, Montr&#xe9;al, QC, Canada. guy.rouleau@mcgill.ca.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurology and Neurosurgery, McGill University, Montr&#xe9;al, QC, Canada. guy.rouleau@mcgill.ca.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>U41 HG007823</GrantID><Acronym>HG</Acronym><Agency>NHGRI NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>11</Month><Day>02</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BMC Med</MedlineTA><NlmUniqueID>101190723</NlmUniqueID><ISSNLinking>1741-7015</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057182" MajorTopicYN="N">Mendelian Randomization Analysis</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D055106" MajorTopicYN="N">Genome-Wide Association Study</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020641" MajorTopicYN="N">Polymorphism, Single Nucleotide</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001327" MajorTopicYN="Y">Autoimmune Diseases</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Amyotrophic lateral sclerosis</Keyword><Keyword MajorTopicYN="N">Autoimmune disorders</Keyword><Keyword MajorTopicYN="N">Causal relationship</Keyword><Keyword MajorTopicYN="N">Mendelian randomization</Keyword></KeywordList><CoiStatement>The authors declare that they have no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>4</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>9</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>11</Month><Day>2</Day><Hour>0</Hour><Minute>48</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>11</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>11</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36320012</ArticleId><ArticleId IdType="pmc">PMC9628014</ArticleId><ArticleId IdType="doi">10.1186/s12916-022-02578-9</ArticleId><ArticleId IdType="pii">10.1186/s12916-022-02578-9</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Brown RH, Al-Chalabi A. Amyotrophic lateral sclerosis. N Engl J Med. 2017;377(2):162&#x2013;172. doi: 10.1056/NEJMra1603471.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMra1603471</ArticleId><ArticleId IdType="pubmed">28700839</ArticleId></ArticleIdList></Reference><Reference><Citation>Taylor JP, Brown RH, Cleveland DW. Decoding ALS: from genes to mechanism. Nature. 2016;539(7628):197&#x2013;206. doi: 10.1038/nature20413.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature20413</ArticleId><ArticleId IdType="pmc">PMC5585017</ArticleId><ArticleId IdType="pubmed">27830784</ArticleId></ArticleIdList></Reference><Reference><Citation>Chio A, Logroscino G, Hardiman O, Swingler R, Mitchell D, Beghi E, et al. Prognostic factors in ALS: a critical review. Amyotroph Lateral Scler. 2009;10(5-6):310&#x2013;323. doi: 10.3109/17482960802566824.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/17482960802566824</ArticleId><ArticleId IdType="pmc">PMC3515205</ArticleId><ArticleId IdType="pubmed">19922118</ArticleId></ArticleIdList></Reference><Reference><Citation>Gladman M, Zinman L. The economic impact of amyotrophic lateral sclerosis: a systematic review. Expert Rev Pharmacoecon Outcomes Res. 2015;15(3):439&#x2013;450. doi: 10.1586/14737167.2015.1039941.</Citation><ArticleIdList><ArticleId IdType="doi">10.1586/14737167.2015.1039941</ArticleId><ArticleId IdType="pubmed">25924979</ArticleId></ArticleIdList></Reference><Reference><Citation>Cooper-Knock J, Jenkins T, Shaw PJ. editors. Clinical and molecular aspects of motor neuron disease. Colloq Ser Genomic Mol Med. 2013;2(2):1&#x2013;60. doi: 10.4199/C00093ED1V01Y201309GMM004.</Citation><ArticleIdList><ArticleId IdType="doi">10.4199/C00093ED1V01Y201309GMM004</ArticleId></ArticleIdList></Reference><Reference><Citation>Ryan M, Heverin M, McLaughlin RL, Hardiman O. Lifetime risk and heritability of amyotrophic lateral sclerosis. JAMA Neurol. 2019;76(11):1367&#x2013;1374. doi: 10.1001/jamaneurol.2019.2044.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2019.2044</ArticleId><ArticleId IdType="pmc">PMC6646974</ArticleId><ArticleId IdType="pubmed">31329211</ArticleId></ArticleIdList></Reference><Reference><Citation>Trabjerg BB, Garton FC, van Rheenen W, Fang F, Henderson RD, Mortensen PB, et al. ALS in Danish Registries: Heritability and links to psychiatric and cardiovascular disorders.&#xa0;Neurol Genet. 2020;6(2).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7073454</ArticleId><ArticleId IdType="pubmed">32211514</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang R, Hadlock KG, Do H, Yu S, Honrada R, Champion S, et al. Gene expression profiling in peripheral blood mononuclear cells from patients with sporadic amyotrophic lateral sclerosis (sALS) J Neuroimmunol. 2011;230(1-2):114&#x2013;123. doi: 10.1016/j.jneuroim.2010.08.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jneuroim.2010.08.012</ArticleId><ArticleId IdType="pmc">PMC3448551</ArticleId><ArticleId IdType="pubmed">20884065</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang R, Gascon R, Miller RG, Gelinas DF, Mass J, Hadlock K, et al. Evidence for systemic immune system alterations in sporadic amyotrophic lateral sclerosis (sALS) J Neuroimmunol. 2005;159(1-2):215&#x2013;224. doi: 10.1016/j.jneuroim.2004.10.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jneuroim.2004.10.009</ArticleId><ArticleId IdType="pubmed">15652422</ArticleId></ArticleIdList></Reference><Reference><Citation>Prinz M, Priller J. The role of peripheral immune cells in the CNS in steady state and disease. Nat Neurosci. 2017;20(2):136&#x2013;144. doi: 10.1038/nn.4475.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.4475</ArticleId><ArticleId IdType="pubmed">28092660</ArticleId></ArticleIdList></Reference><Reference><Citation>Murdock BJ, Zhou T, Kashlan SR, Little RJ, Goutman SA, Feldman EL. Correlation of peripheral immunity with rapid amyotrophic lateral sclerosis progression. JAMA Neurol. 2017;74(12):1446&#x2013;1454. doi: 10.1001/jamaneurol.2017.2255.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2017.2255</ArticleId><ArticleId IdType="pmc">PMC5822195</ArticleId><ArticleId IdType="pubmed">28973548</ArticleId></ArticleIdList></Reference><Reference><Citation>Mccombe PA, Henderson RD. The role of immune and inflammatory mechanisms in ALS. Curr Mol Med. 2011;11(3):246&#x2013;254. doi: 10.2174/156652411795243450.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/156652411795243450</ArticleId><ArticleId IdType="pmc">PMC3182412</ArticleId><ArticleId IdType="pubmed">21375489</ArticleId></ArticleIdList></Reference><Reference><Citation>Kawamata T, Akiyama H, Yamada T, McGeer P. Immunologic reactions in amyotrophic lateral sclerosis brain and spinal cord tissue. Am J Clin Pathol. 1992;140(3):691.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1886170</ArticleId><ArticleId IdType="pubmed">1347673</ArticleId></ArticleIdList></Reference><Reference><Citation>Henkel JS, Engelhardt JI, Sikl&#xf3;s L, Simpson EP, Kim SH, Pan T, et al. Presence of dendritic cells, MCP-1, and activated microglia/macrophages in amyotrophic lateral sclerosis spinal cord tissue. Ann Neurol. 2004;55(2):221&#x2013;235. doi: 10.1002/ana.10805.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.10805</ArticleId><ArticleId IdType="pubmed">14755726</ArticleId></ArticleIdList></Reference><Reference><Citation>Henkel JS, Beers DR, Wen S, Rivera AL, Toennis KM, Appel JE, et al. Regulatory T-lymphocytes mediate amyotrophic lateral sclerosis progression and survival. EMBO Mol Med. 2013;5(1):64&#x2013;79. doi: 10.1002/emmm.201201544.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/emmm.201201544</ArticleId><ArticleId IdType="pmc">PMC3569654</ArticleId><ArticleId IdType="pubmed">23143995</ArticleId></ArticleIdList></Reference><Reference><Citation>Duarte F, Binet S, Lacomblez L, Bouche P, Preud&#x2019;homme J-L, Meininger V. Quantitative analysis of monoclonal immunoglobulins in serum of patients with amyotrophic lateral sclerosis. J Neurol Sci. 1991;104(1):88&#x2013;91. doi: 10.1016/0022-510X(91)90220-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0022-510X(91)90220-2</ArticleId><ArticleId IdType="pubmed">1919600</ArticleId></ArticleIdList></Reference><Reference><Citation>Turner MR, Goldacre R, Ramagopalan S, Talbot K, Goldacre MJ. Autoimmune disease preceding amyotrophic lateral sclerosis: an epidemiologic study. Neurology. 2013;81(14):1222&#x2013;1225. doi: 10.1212/WNL.0b013e3182a6cc13.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0b013e3182a6cc13</ArticleId><ArticleId IdType="pmc">PMC3795611</ArticleId><ArticleId IdType="pubmed">23946298</ArticleId></ArticleIdList></Reference><Reference><Citation>Burgess S, Small DS, Thompson SG. A review of instrumental variable estimators for Mendelian randomization. Stat Methodol. 2017;26(5):2333&#x2013;2355.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5642006</ArticleId><ArticleId IdType="pubmed">26282889</ArticleId></ArticleIdList></Reference><Reference><Citation>Davies NM, Holmes MV, Smith GD. Reading Mendelian randomisation studies: a guide, glossary, and checklist for clinicians. BMJ. 2018;362.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6041728</ArticleId><ArticleId IdType="pubmed">30002074</ArticleId></ArticleIdList></Reference><Reference><Citation>Buniello A, MacArthur JAL, Cerezo M, Harris LW, Hayhurst J, Malangone C, et al. The NHGRI-EBI GWAS Catalog of published genome-wide association studies, targeted arrays and summary statistics 2019. Nucleic Acids Res. 2019;47(D1):D1005&#x2013;D1D12. doi: 10.1093/nar/gky1120.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gky1120</ArticleId><ArticleId IdType="pmc">PMC6323933</ArticleId><ArticleId IdType="pubmed">30445434</ArticleId></ArticleIdList></Reference><Reference><Citation>GWAS Catalog. https://www.ebi.ac.uk/gwas/downloads/summary-statistics. Accessed 20 March 2022.</Citation></Reference><Reference><Citation>IEU OpenGWAS project. https://gwas.mrcieu.ac.uk. Accessed 20 March 2022.</Citation></Reference><Reference><Citation>van Rheenen W, van der Spek R, Bakker M, van den Berg L, Veldink J, van Vugt J, et al. Common and rare variant association analyses in amyotrophic lateral sclerosis identify 15 risk loci with distinct genetic architectures and neuron-specific biology. Nat Genet. 2021;53(12):1636&#x2013;1648. doi: 10.1038/s41588-021-00973-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41588-021-00973-1</ArticleId><ArticleId IdType="pmc">PMC8648564</ArticleId><ArticleId IdType="pubmed">34873335</ArticleId></ArticleIdList></Reference><Reference><Citation>Project MinE. https://www.projectmine.com. Accessed 20 March 2022.</Citation></Reference><Reference><Citation>Valette K, Li Z, Bon-Baret V, Chignon A, B&#xe9;rub&#xe9; J-C, Eslami A, et al. Prioritization of candidate causal genes for asthma in susceptibility loci derived from UK Biobank. Commun Biol. 2021;4(1):1&#x2013;15. doi: 10.1038/s42003-021-02227-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s42003-021-02227-6</ArticleId><ArticleId IdType="pmc">PMC8187656</ArticleId><ArticleId IdType="pubmed">34103634</ArticleId></ArticleIdList></Reference><Reference><Citation>De Lange KM, Moutsianas L, Lee JC, Lamb CA, Luo Y, Kennedy NA, et al. Genome-wide association study implicates immune activation of multiple integrin genes in inflammatory bowel disease. Nat Genet. 2017;49(2):256&#x2013;261. doi: 10.1038/ng.3760.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng.3760</ArticleId><ArticleId IdType="pmc">PMC5289481</ArticleId><ArticleId IdType="pubmed">28067908</ArticleId></ArticleIdList></Reference><Reference><Citation>Trynka G, Hunt KA, Bockett NA, Romanos J, Mistry V, Szperl A, et al. Dense genotyping identifies and localizes multiple common and rare variant association signals in celiac disease. Nat Genet. 2011;43(12):1193&#x2013;1201. doi: 10.1038/ng.998.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng.998</ArticleId><ArticleId IdType="pmc">PMC3242065</ArticleId><ArticleId IdType="pubmed">22057235</ArticleId></ArticleIdList></Reference><Reference><Citation>Eijsbouts C, Zheng T, Kennedy NA, Bonfiglio F, Anderson CA, Moutsianas L, et al. Genome-wide analysis of 53,400 people with irritable bowel syndrome highlights shared genetic pathways with mood and anxiety disorders. Nat Genet. 2021;53(11):1543&#x2013;1552. doi: 10.1038/s41588-021-00950-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41588-021-00950-8</ArticleId><ArticleId IdType="pmc">PMC8571093</ArticleId><ArticleId IdType="pubmed">34741163</ArticleId></ArticleIdList></Reference><Reference><Citation>Consortium IMSG, ANZgene, IIBDGC, WTCCC2 Multiple sclerosis genomic map implicates peripheral immune cells and microglia in susceptibility. Science. 2019;365(6460):eaav7188. doi: 10.1126/science.aav7188.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aav7188</ArticleId><ArticleId IdType="pmc">PMC7241648</ArticleId><ArticleId IdType="pubmed">31604244</ArticleId></ArticleIdList></Reference><Reference><Citation>Cordell HJ, Fryett JJ, Ueno K, Darlay R, Aiba Y, Hitomi Y, et al. An international genome-wide meta-analysis of primary biliary cholangitis: novel risk loci and candidate drugs. J Hepatol. 2021;75(3):572&#x2013;581. doi: 10.1016/j.jhep.2021.04.055.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jhep.2021.04.055</ArticleId><ArticleId IdType="pmc">PMC8811537</ArticleId><ArticleId IdType="pubmed">34033851</ArticleId></ArticleIdList></Reference><Reference><Citation>Ji S-G, Juran BD, Mucha S, Folseraas T, Jostins L, Melum E, et al. Genome-wide association study of primary sclerosing cholangitis identifies new risk loci and quantifies the genetic relationship with inflammatory bowel disease. Nat Genet. 2017;49(2):269&#x2013;273. doi: 10.1038/ng.3745.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng.3745</ArticleId><ArticleId IdType="pmc">PMC5540332</ArticleId><ArticleId IdType="pubmed">27992413</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsoi LC, Spain SL, Knight J, Ellinghaus E, Stuart PE, Capon F, et al. Identification of 15 new psoriasis susceptibility loci highlights the role of innate immunity. Nat Genet. 2012;44(12):1341&#x2013;1348. doi: 10.1038/ng.2467.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng.2467</ArticleId><ArticleId IdType="pmc">PMC3510312</ArticleId><ArticleId IdType="pubmed">23143594</ArticleId></ArticleIdList></Reference><Reference><Citation>Okada Y, Wu D, Trynka G, Raj T, Terao C, Ikari K, et al. Genetics of rheumatoid arthritis contributes to biology and drug discovery. Nature. 2014;506(7488):376&#x2013;381. doi: 10.1038/nature12873.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature12873</ArticleId><ArticleId IdType="pmc">PMC3944098</ArticleId><ArticleId IdType="pubmed">24390342</ArticleId></ArticleIdList></Reference><Reference><Citation>Forgetta V, Manousaki D, Istomine R, Ross S, Tessier M-C, Marchand L, et al. Rare genetic variants of large effect influence risk of type 1 diabetes. Diabetes. 2020;69(4):784&#x2013;795. doi: 10.2337/db19-0831.</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/db19-0831</ArticleId><ArticleId IdType="pmc">PMC7085253</ArticleId><ArticleId IdType="pubmed">32005708</ArticleId></ArticleIdList></Reference><Reference><Citation>Bentham J, Morris DL, Graham DSC, Pinder CL, Tombleson P, Behrens TW, et al. Genetic association analyses implicate aberrant regulation of innate and adaptive immunity genes in the pathogenesis of systemic lupus erythematosus. Nat Genet. 2015;47(12):1457&#x2013;1464. doi: 10.1038/ng.3434.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng.3434</ArticleId><ArticleId IdType="pmc">PMC4668589</ArticleId><ArticleId IdType="pubmed">26502338</ArticleId></ArticleIdList></Reference><Reference><Citation>Hemani G, Tilling K, Davey SG. Orienting the causal relationship between imprecisely measured traits using GWAS summary data. PLoS Genet. 2017;13(11):e1007081. doi: 10.1371/journal.pgen.1007081.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pgen.1007081</ArticleId><ArticleId IdType="pmc">PMC5711033</ArticleId><ArticleId IdType="pubmed">29149188</ArticleId></ArticleIdList></Reference><Reference><Citation>Hemani G, Zheng J, Elsworth B, Wade KH, Haberland V, Baird D, et al. The MR-Base platform supports systematic causal inference across the human phenome. Elife. 2018;7:e34408. doi: 10.7554/eLife.34408.</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.34408</ArticleId><ArticleId IdType="pmc">PMC5976434</ArticleId><ArticleId IdType="pubmed">29846171</ArticleId></ArticleIdList></Reference><Reference><Citation>Matzaraki V, Kumar V, Wijmenga C, Zhernakova A. The MHC locus and genetic susceptibility to autoimmune and infectious diseases. Genome Biol. 2017;18(1):1&#x2013;21. doi: 10.1186/s13059-017-1207-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13059-017-1207-1</ArticleId><ArticleId IdType="pmc">PMC5406920</ArticleId><ArticleId IdType="pubmed">28449694</ArticleId></ArticleIdList></Reference><Reference><Citation>Burgess S, Thompson SG, Collaboration CCG. Avoiding bias from weak instruments in Mendelian randomization studies. Int J Epidemiol. 2011;40(3):755&#x2013;764. doi: 10.1093/ije/dyr036.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ije/dyr036</ArticleId><ArticleId IdType="pubmed">21414999</ArticleId></ArticleIdList></Reference><Reference><Citation>Burgess S. Sample size and power calculations in Mendelian randomization with a single instrumental variable and a binary outcome. Int J Epidemiol. 2014;43(3):922&#x2013;929. doi: 10.1093/ije/dyu005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ije/dyu005</ArticleId><ArticleId IdType="pmc">PMC4052137</ArticleId><ArticleId IdType="pubmed">24608958</ArticleId></ArticleIdList></Reference><Reference><Citation>Online sample size and power calculator for Mendelian randomization with a binary outcome. https://sb452.shinyapps.io/power/. Accessed 20 March 2022.</Citation></Reference><Reference><Citation>Bowden J, Davey Smith G, Burgess S. Mendelian randomization with invalid instruments: effect estimation and bias detection through Egger regression. Int J Epidemiol. 2015;44(2):512&#x2013;525. doi: 10.1093/ije/dyv080.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ije/dyv080</ArticleId><ArticleId IdType="pmc">PMC4469799</ArticleId><ArticleId IdType="pubmed">26050253</ArticleId></ArticleIdList></Reference><Reference><Citation>Burgess S, Butterworth A, Thompson SG. Mendelian randomization analysis with multiple genetic variants using summarized data. Genet Epidemiol. 2013;37(7):658&#x2013;665. doi: 10.1002/gepi.21758.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/gepi.21758</ArticleId><ArticleId IdType="pmc">PMC4377079</ArticleId><ArticleId IdType="pubmed">24114802</ArticleId></ArticleIdList></Reference><Reference><Citation>Burgess S, Bowden J, Fall T, Ingelsson E, Thompson SG. Sensitivity analyses for robust causal inference from Mendelian randomization analyses with multiple genetic variants. Epidemiology. 2017;28(1):30. doi: 10.1097/EDE.0000000000000559.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/EDE.0000000000000559</ArticleId><ArticleId IdType="pmc">PMC5133381</ArticleId><ArticleId IdType="pubmed">27749700</ArticleId></ArticleIdList></Reference><Reference><Citation>Bowden J, Davey Smith G, Haycock PC, Burgess S. Consistent estimation in Mendelian randomization with some invalid instruments using a weighted median estimator. Genet Epidemiol. 2016;40(4):304&#x2013;314. doi: 10.1002/gepi.21965.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/gepi.21965</ArticleId><ArticleId IdType="pmc">PMC4849733</ArticleId><ArticleId IdType="pubmed">27061298</ArticleId></ArticleIdList></Reference><Reference><Citation>Bowden J, Del Greco MF, Minelli C, Zhao Q, Lawlor DA, Sheehan NA, et al. Improving the accuracy of two-sample summary-data Mendelian randomization: moving beyond the NOME assumption. Int J Epidemiol. 2019;48(3):728&#x2013;742. doi: 10.1093/ije/dyy258.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ije/dyy258</ArticleId><ArticleId IdType="pmc">PMC6659376</ArticleId><ArticleId IdType="pubmed">30561657</ArticleId></ArticleIdList></Reference><Reference><Citation>Verbanck M, Chen C-y, Neale B, Do R. Detection of widespread horizontal pleiotropy in causal relationships inferred from Mendelian randomization between complex traits and diseases. Nat Genet. 2018;50(5):693&#x2013;698. doi: 10.1038/s41588-018-0099-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41588-018-0099-7</ArticleId><ArticleId IdType="pmc">PMC6083837</ArticleId><ArticleId IdType="pubmed">29686387</ArticleId></ArticleIdList></Reference><Reference><Citation>McGovern DP, Gardet A, T&#xf6;rkvist L, Goyette P, Essers J, Taylor KD, et al. Genome-wide association identifies multiple ulcerative colitis susceptibility loci. Nat Genet. 2010;42(4):332&#x2013;337. doi: 10.1038/ng.549.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng.549</ArticleId><ArticleId IdType="pmc">PMC3087600</ArticleId><ArticleId IdType="pubmed">20228799</ArticleId></ArticleIdList></Reference><Reference><Citation>Burgess S, Thompson SG. Multivariable Mendelian randomization: the use of pleiotropic genetic variants to estimate causal effects. Am J Epidemiol. 2015;181(4):251&#x2013;260. doi: 10.1093/aje/kwu283.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/aje/kwu283</ArticleId><ArticleId IdType="pmc">PMC4325677</ArticleId><ArticleId IdType="pubmed">25632051</ArticleId></ArticleIdList></Reference><Reference><Citation>Burgess S, Smith GD, Davies NM, Dudbridge F, Gill D, Glymour MM, et al. Guidelines for performing Mendelian randomization investigations. Wellcome Open Res. 2019;4.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7384151</ArticleId><ArticleId IdType="pubmed">32760811</ArticleId></ArticleIdList></Reference><Reference><Citation>Bowden J, Hemani G, Davey SG. Invited commentary: detecting individual and global horizontal pleiotropy in Mendelian randomization&#x2014;a job for the humble heterogeneity statistic? Am J Epidemiol. 2018;187(12):2681&#x2013;2685.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6269239</ArticleId><ArticleId IdType="pubmed">30188969</ArticleId></ArticleIdList></Reference><Reference><Citation>Li CY, Yang TM, Ou RW, Wei QQ, Shang HF. Genome-wide genetic links between amyotrophic lateral sclerosis and autoimmune diseases. BMC Med. 2021;19(1):1&#x2013;11. doi: 10.1186/s12916-021-01903-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12916-021-01903-y</ArticleId><ArticleId IdType="pmc">PMC7863260</ArticleId><ArticleId IdType="pubmed">33541344</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>